TAIPEI, Feb. 18, 2011 /PRNewswire-Asia-FirstCall/ — Golden
Meditech Holdings (“Golden Meditech,” 0801.HK, 910801.TW) and Long
Bon International Co., Limited (“Long Bon International”) today
announced that the companies have entered into a memorandum of
understanding (MOU) for strategic cooperation in Taipei.
Golden Meditech Holdings Chairman, Mr. Kam Yuen and Chairman
of Long Bon International, Mr. Chu Powei, respectively represented
and co-chaired the signing ceremony. Per the MOU, the parties
will establish a joint-venture company within the next six months
to capture business opportunities within the healthcare sector
arising from the introduction of ECFA. This will be the first
collaborative effort between two sizable corporations to penetrate
the healthcare sector and healthcare services across the Straits
with the advantage of creating considerable synergies that would
complement the strengths of both parties.
In reference to the MOU, both Golden Meditech and Long Bon
International will leverage on each others’ resources and
competitive advantages on the basis of their existing operations to
synergistically facilitate market penetration and enhance their
respective healthcare businesses, specifically via establishing a
joint-venture operation in Taiwan. The joint effort will be
instrumental to stipulate both parties’ growth in both mainland
China and Taiwan markets.
Mr. Kam Yuen, Chairman of Golden Meditech commented, “The next
decade will be a golden opportunity for the development of the
healthcare industry in mainland China, as the medical reforms
progresses forward, on the back of the launch of ECFA, there will
likely be a speeding up in consolidation within the industry.
In addition to our focus in mainland China, Golden Meditech
is also actively pursuing business opportunities within the Taiwan
markets, capitalizing on the competitive advantages of Long Bon
International, to catapult growth in our core bus
‘/>”/>
